Evidence map›Paper›PMID 33777659›Full record

ArticleCurrent stem cell reports2020

The role of RNA epigenetic modification in normal and malignant hematopoiesis.

Radovan Vasic, Yimeng Gao, Chengyang Liu, Stephanie Halene

Open access · bronzeAbstract read
In one paragraph

Article in Current stem cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. RNA modifications in hematological malignancies.International journal of hematology · 2023
    Review
  3. The NNature communications · 2022
    Article
  4. NBioengineered · 2022
    Article
  5. Roles of RNA Modifications in Diverse Cellular Functions.Frontiers in cell and developmental biology · 2022
    Review
  6. Review
  7. Article
  8. Gene Characteristics and Prognostic Values of mJournal of healthcare engineering · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Radovan VasicSection of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Yimeng GaoSection of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Chengyang LiuSection of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Stephanie HaleneSection of Hematology, Yale Cancer Center and Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Yale University · USUniversity of Toronto · CA

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
Mechanisms of Leukemogenesis in AMKLR01CA222518 · NCI · YALE UNIVERSITY · PI HALENE, STEPHANIE, KRAUSE, DIANE S · 2020 to 2024
$3.0M
The role of mutant splicing factor SRSF2 in MyelodysplasiaR01DK102792 · NIDDK · YALE UNIVERSITY · PI HALENE, STEPHANIE · 2016 to 2019
$1.5M
NCATS NIH HHS UL1 TR001863NCI NIH HHS R01 CA222518NIDDK NIH HHS R01 DK102792NIDDK NIH HHS U54 DK106857
6 · The paper itself

Abstract

purpose of reviewRNA epigenetic modifications have been identified as novel, dynamic regulators of gene expression, with important impacts on stem cell fate decisions. Here we examine the functions of RNA modifications, with a focus on RECENT

findingsThe m SUMMARY: The RNA modification m

Indexed as

dsRNAhematopoiesism6AN6-methyladenosineRNA modification

Identifiers

PMID33777659
PMCPMC7992056
OpenAlexW3048642618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.